The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer — but it doesn’t cure the disease and only works if the cancer is treated early.
About the Author
The newly developed treatment daraxonrasib can double the years left to live for patients with pancreatic cancer — but it doesn’t cure the disease and only works if the cancer is treated early.